HOG
56
4
AEE
63
2
IBM
78
-3
HSIC
57
6
QRVO
47
-5
COP
47
7
PEG
74
2
SCHW
49
4
LB
30
-4
MHK
56
3
IVZ
63
-3
ADM
30
2
CHRW
53
2
FLS
63
-6
MCK
46
2
NTAP
60
-4
HST
40
-12
CAT
70
-2
CAG
36
-10
GE
81
2
HOG
56
4
AEE
63
2
IBM
78
-3
HSIC
57
6
QRVO
47
-5
COP
47
7
PEG
74
2
SCHW
49
4
LB
30
-4
MHK
56
3
IVZ
63
-3
ADM
30
2
CHRW
53
2
FLS
63
-6
MCK
46
2
NTAP
60
-4
HST
40
-12
CAT
70
-2
CAG
36
-10
GE
81
2
Financhill
Back

CervoMed Quote, Financials, Valuation and Earnings

Invest in the Next Big AI Disruptor Today

Learn More
Sell
23

CRVO
CervoMed

Last Price:
15.08
Seasonality Move:
-20.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest in This AI Tech Innovator Doubling Revenue

Invest Now!

CervoMed Price Quote

$15.08
-0.05 (-1.5%)
(Updated: September 28, 2024 at 6:26 AM ET)

CervoMed Key Stats

Sell
23
CervoMed (CRVO) is a Sell
Day range:
$14.52 - $15.64
52-week range:
$4.61 - $26.38
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
132.37
P/B ratio:
2.5%
Volume:
52.5K
Avg. volume:
84.1K
1-year change:
225.38%
Market cap:
$124.9M
Revenue:
$0
EPS:
$-1.8

How Much Does CervoMed Make?

Data Unavailable

Is CervoMed Growing As A Company?

Data Unavailable

CervoMed Stock Price Performance

  • Did CervoMed Stock Go Up Last Month?
    CervoMed share price went down by -9.24% last month
  • Did CRVO's Share Price Rise Over The Last Year?
    CRVO share price rose by 225.38% over the past 1 year

What Is CervoMed 52-Week High & Low?

  • What Is CervoMed’s 52-Week High Share Price?
    CervoMed has traded as high as $26.38 over the past 52 weeks
  • What Is CervoMed’s 52-Week Low Share Price?
    CervoMed has traded as low as $4.61 over the past 52 weeks

CervoMed Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy CervoMed?

  • How Much Debt Does CervoMed Have?
    Total long term debt quarterly is $0
  • How Much Cash Does CervoMed Have?
    Cash and short term investments quarterly total is $45.1M
  • What Is CervoMed’s Book Value Per Share?
    Book value per share is 6.06

Is CervoMed Cash Flow Positive?

  • What Is CRVO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$7.6M
  • What Is CervoMed’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is CervoMed’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

CervoMed Return On Invested Capital

Data Unavailable

CervoMed Earnings Date & Stock Price

  • What Is CervoMed's Stock Price Today?
    A single share of CRVO can be purchased today for 15.13
  • What Is CervoMed’s Stock Symbol?
    CervoMed trades on the nasdaq under the ticker symbol: CRVO
  • When Is CervoMed’s Next Earnings Date?
    The next quarterly earnings date for CervoMed is scheduled on November 13, 2024
  • When Is CRVO's next ex-dividend date?
    CervoMed's next ex-dividend date is September 28, 2024
  • How To Buy CervoMed Stock?
    You can buy CervoMed shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

CervoMed Competitors

  • Who Are CervoMed's Competitors?
    Below is a list of companies who compete with CervoMed or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Armata Pharmaceuticals Inc (ARMP)
    • Perspective Therapeutics Inc (CATX)
    • Elutia Inc (ELUT)
    • Protalix BioTherapeutics Inc (PLX)

CervoMed Dividend Yield

  • What Is CRVO Dividend Yield?
    CervoMed’s dividend yield currently is 0%
  • What Is CervoMed’s Payout Ratio?
    CervoMed’s payout ratio is 0%
  • When Did CervoMed Last Pay A Dividend?
    The latest dividend pay date is September 28, 2024
  • What Is CervoMed’s Dividend Per Share?
    CervoMed pays a dividend of $0.00 per share

CervoMed Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.9%
Revenue: 0% 49.5%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 53.00
Upside from Last Price: 250.3%

Major Shareholders

  • How many CRVO shares are owned by institutional investors?
    5.3M CRVO shares are owned by institutional investors
  • How many CRVO shares are owned by insiders?
    0 CRVO shares are owned by insiders